Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt 0.34
USMD's Cash to Debt is ranked lower than
51% of the 243 Companies
in the Global Medical Care industry.

( Industry Median: 0.34 vs. USMD: 0.34 )
Ranked among companies with meaningful Cash to Debt only.
USMD' s Cash to Debt Range Over the Past 10 Years
Min: 0.21  Med: 0.46 Max: N/A
Current: 0.34
Equity to Asset 0.54
USMD's Equity to Asset is ranked higher than
59% of the 234 Companies
in the Global Medical Care industry.

( Industry Median: 0.47 vs. USMD: 0.54 )
Ranked among companies with meaningful Equity to Asset only.
USMD' s Equity to Asset Range Over the Past 10 Years
Min: 0.38  Med: 0.54 Max: 0.68
Current: 0.54
0.38
0.68
F-Score: 3
Z-Score: 2.45
M-Score: -3.02
WACC vs ROIC
6.57%
-7.80%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) -6.11
USMD's Operating margin (%) is ranked lower than
86% of the 243 Companies
in the Global Medical Care industry.

( Industry Median: 6.97 vs. USMD: -6.11 )
Ranked among companies with meaningful Operating margin (%) only.
USMD' s Operating margin (%) Range Over the Past 10 Years
Min: -12.52  Med: 6.4 Max: 38.45
Current: -6.11
-12.52
38.45
Net-margin (%) -0.46
USMD's Net-margin (%) is ranked lower than
79% of the 244 Companies
in the Global Medical Care industry.

( Industry Median: 4.69 vs. USMD: -0.46 )
Ranked among companies with meaningful Net-margin (%) only.
USMD' s Net-margin (%) Range Over the Past 10 Years
Min: -10.99  Med: 1.21 Max: 13.25
Current: -0.46
-10.99
13.25
ROE (%) -1.06
USMD's ROE (%) is ranked lower than
81% of the 224 Companies
in the Global Medical Care industry.

( Industry Median: 9.37 vs. USMD: -1.06 )
Ranked among companies with meaningful ROE (%) only.
USMD' s ROE (%) Range Over the Past 10 Years
Min: -20.64  Med: 1.44 Max: 53.56
Current: -1.06
-20.64
53.56
ROA (%) -0.56
USMD's ROA (%) is ranked lower than
78% of the 242 Companies
in the Global Medical Care industry.

( Industry Median: 4.28 vs. USMD: -0.56 )
Ranked among companies with meaningful ROA (%) only.
USMD' s ROA (%) Range Over the Past 10 Years
Min: -12.28  Med: 0.92 Max: 20.13
Current: -0.56
-12.28
20.13
ROC (Joel Greenblatt) (%) -61.06
USMD's ROC (Joel Greenblatt) (%) is ranked lower than
95% of the 241 Companies
in the Global Medical Care industry.

( Industry Median: 19.96 vs. USMD: -61.06 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
USMD' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -140.52  Med: 35.98 Max: 726.33
Current: -61.06
-140.52
726.33
Revenue Growth (3Y)(%) 18.80
USMD's Revenue Growth (3Y)(%) is ranked higher than
85% of the 176 Companies
in the Global Medical Care industry.

( Industry Median: 8.00 vs. USMD: 18.80 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
USMD' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 18.8  Med: 28.7 Max: 131.3
Current: 18.8
18.8
131.3
» USMD's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

USMD Guru Trades in

USMD Guru Trades in

USMD Guru Trades in

Q2 2016

USMD Guru Trades in Q2 2016

Jim Simons 22,299 sh (New)
» More
» Details

Insider Trades

Latest Guru Trades with USMD

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care
Compare:AMEX:HLTH, NAS:ADUS, NYSE:QHC, NAS:BIOS, NYSE:CCM, NAS:AFAM, NYSE:AAC, OTCPK:CATS, OTCPK:BRRZF, OTCPK:CRNJF, NAS:JYNT, OTCPK:FCHS, OTCPK:CCEL, OTCPK:FDNH, OTCPK:BNKL, OTCPK:AMEH, OTCPK:CVHIF, AMEX:AMS, AMEX:HH, AMEX:SSY » details
USMD Holdings Inc is a health care management company. The Company provides healthcare services to patients and management and operational services to hospitals and other healthcare service providers.

USMD Holdings Inc is a Delaware corporation formed on May 7, 2010. The Company is a health care management company. It provides healthcare services to patients and management and operational services to hospitals and other healthcare service providers. The Company provides healthcare services to patients in physician clinics, hospitals and other healthcare facilities, including cancer treatment centers and anatomical pathology and clinical laboratories. A wholly owned subsidiary of the Company is the sole member of a Texas Certified Non-Profit Health Organization that owns and operates a multi-specialty physician group practice (USMD Physician Services) in the Dallas-Fort Worth, Texas metropolitan area. Through other wholly owned subsidiaries, the Company provides management and operational services to two short-stay hospitals in the Dallas-Fort Worth, Texas metropolitan area and provides management and/or operational services to three cancer treatment centers in three states and 22 lithotripsy service providers (i.e., kidney stone treatment) located in the South-Central United States. Of these managed entities, the Company has limited ownership interests in the two hospitals, two cancer treatment centers and 20 lithotripsy service providers. In addition, the Company wholly owns and operates two clinical laboratories, one anatomical pathology laboratory, one cancer treatment center and two lithotripsy service providers in the Dallas-Fort Worth, Texas metropolitan area. The Company operates in one physician-led integrated health system segment. It competes for patients with other integrated health systems, physician practices, hospitals, outpatient surgery centers, diagnostic facilities and other free-standing facilities.

Ratios

vs
industry
vs
history
P/B 1.78
USMD's P/B is ranked higher than
69% of the 219 Companies
in the Global Medical Care industry.

( Industry Median: 2.54 vs. USMD: 1.78 )
Ranked among companies with meaningful P/B only.
USMD' s P/B Range Over the Past 10 Years
Min: 0.43  Med: 0.79 Max: 2.03
Current: 1.78
0.43
2.03
P/S 0.73
USMD's P/S is ranked higher than
76% of the 234 Companies
in the Global Medical Care industry.

( Industry Median: 1.50 vs. USMD: 0.73 )
Ranked among companies with meaningful P/S only.
USMD' s P/S Range Over the Past 10 Years
Min: 0.22  Med: 0.49 Max: 2.41
Current: 0.73
0.22
2.41
Current Ratio 1.46
USMD's Current Ratio is ranked higher than
56% of the 228 Companies
in the Global Medical Care industry.

( Industry Median: 1.32 vs. USMD: 1.46 )
Ranked among companies with meaningful Current Ratio only.
USMD' s Current Ratio Range Over the Past 10 Years
Min: 1.18  Med: 1.4 Max: 2.79
Current: 1.46
1.18
2.79
Quick Ratio 1.42
USMD's Quick Ratio is ranked higher than
57% of the 228 Companies
in the Global Medical Care industry.

( Industry Median: 1.22 vs. USMD: 1.42 )
Ranked among companies with meaningful Quick Ratio only.
USMD' s Quick Ratio Range Over the Past 10 Years
Min: 1.13  Med: 1.36 Max: 2.79
Current: 1.42
1.13
2.79
Days Sales Outstanding 31.49
USMD's Days Sales Outstanding is ranked higher than
69% of the 196 Companies
in the Global Medical Care industry.

( Industry Median: 43.71 vs. USMD: 31.49 )
Ranked among companies with meaningful Days Sales Outstanding only.
USMD' s Days Sales Outstanding Range Over the Past 10 Years
Min: 19  Med: 33.19 Max: 71.19
Current: 31.49
19
71.19

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -4.10
USMD's 3-Year Average Share Buyback Ratio is ranked lower than
57% of the 125 Companies
in the Global Medical Care industry.

( Industry Median: -2.40 vs. USMD: -4.10 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
USMD' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -41.5  Med: -4.1 Max: 30.2
Current: -4.1
-41.5
30.2

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 6.09
USMD's Price/Tangible Book is ranked lower than
69% of the 167 Companies
in the Global Medical Care industry.

( Industry Median: 3.61 vs. USMD: 6.09 )
Ranked among companies with meaningful Price/Tangible Book only.
USMD' s Price/Tangible Book Range Over the Past 10 Years
Min: 1.82  Med: 4.36 Max: 17.3
Current: 6.09
1.82
17.3
Price/Projected FCF 0.91
USMD's Price/Projected FCF is ranked higher than
81% of the 94 Companies
in the Global Medical Care industry.

( Industry Median: 1.68 vs. USMD: 0.91 )
Ranked among companies with meaningful Price/Projected FCF only.
USMD' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.38  Med: 0.57 Max: 0.91
Current: 0.91
0.38
0.91
Price/Median PS Value 1.48
USMD's Price/Median PS Value is ranked lower than
75% of the 204 Companies
in the Global Medical Care industry.

( Industry Median: 1.06 vs. USMD: 1.48 )
Ranked among companies with meaningful Price/Median PS Value only.
USMD' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.47  Med: 0.87 Max: 3.27
Current: 1.48
0.47
3.27
Earnings Yield (Greenblatt) (%) -6.90
USMD's Earnings Yield (Greenblatt) (%) is ranked lower than
90% of the 231 Companies
in the Global Medical Care industry.

( Industry Median: 4.00 vs. USMD: -6.90 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
USMD' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: -6.9  Med: 4 Max: 19.1
Current: -6.9
-6.9
19.1

More Statistics

Revenue (TTM) (Mil) $329.5
EPS (TTM) $ -0.09
Beta0.82
Short Percentage of Float1.84%
52-Week Range $6.53 - 23.04
Shares Outstanding (Mil)11.39
» More Articles for USMD

Headlines

Articles On GuruFocus.com
No related article found.

More From Other Websites
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of... Aug 30 2016
USMD HOLDINGS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in... Aug 30 2016
USMD HOLDINGS, INC. Financials Aug 20 2016
USMD Holdings, Inc. :USMD-US: Earnings Analysis: Q2, 2016 By the Numbers : August 18, 2016 Aug 18 2016
USMD reports 2Q loss Aug 12 2016
USMD reports 2Q loss Aug 12 2016
USMD HOLDINGS, INC. Files SEC form 10-Q, Quarterly Report Aug 12 2016
USMD and UnitedHealthcare to Improve Patients' Care in Dallas/Fort Worth Jul 20 2016
ETF’s with exposure to USMD Holdings, Inc. : July 1, 2016 Jul 01 2016
Ten USMD Physicians Named Mom-Approved Doctors by DFW Child Magazine Jun 09 2016
ETF’s with exposure to USMD Holdings, Inc. : June 6, 2016 Jun 06 2016
USMD Holdings, Inc. :USMD-US: Earnings Analysis: Q1, 2016 By the Numbers : May 23, 2016 May 23 2016
USMD HOLDINGS, INC. Files SEC form 10-Q, Quarterly Report May 16 2016
USMD HOLDINGS, INC. Files SEC form 10-K, Annual Report Apr 14 2016
USMD Appoints Michael W. Bukosky Chief Operating Officer of USMD Holdings Mar 01 2016
USMD HOLDINGS, INC. Files SEC form 8-K, Change in Directors or Principal Officers Feb 10 2016
USMD Health System Adds Orthopedic Surgery to its Growing List of Specialties Jan 26 2016
UNIVERSITY SYSTEM OF MARYLAND, MD -- Moody's assigns Aa1 to University System of Maryland's Series... Jan 22 2016
USMD HOLDINGS, INC. Files SEC form 8-K, Change in Directors or Principal Officers Jan 21 2016
USMD Health System Announces the Sale of Its Lithotripsy Division to United Medical Systems Dec 24 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)